Multiple sclerosis (MS) is a chronic inflammatory disorder that is thought to impact about 2.3 million people around the ...

A trial using PET scans to test the anti-inflammatory drug PIPE-791 finished enrolling healthy volunteers and patients with ...

Older men with MS who used androgen-modifying therapies showed unexpectedly sustained or increased disease activity in a ...

Individual expectations about one's health can influence him/her future condition and the speed of the progression of a ...

UC Riverside study may lead to new treatments for multiple sclerosis. Multiple sclerosis (MS) affects an estimated 2.3 ...

Read full-text medical journal articles from Medscape's Multiple Sclerosis: Latest. X. No Results. No Results. For You News ... Eliminates Disease Activity A second-generation anti-CD40 therapy that ...

The findings contradict previous research suggesting high-risk patients with multiple myeloma were more likely to have a ...

A blood test might predict when multiple sclerosis patients are about to suffer a relapse in their symptoms, a new study says ...

Recent highlights in MS coverage focus on biomarkers, pregnancy, and neurodegeneration. Physician’s Weekly has compiled a ...

A study of twins reveals two gut bacteria linked to multiple sclerosis, offering new targets for future treatments.

An engineered protein turns off the kind of immune cells most likely to damage tissue as part of Type-1 diabetes, hepatitis, ...

Tiziana (TLSA) is showing groundbreaking advancements in Alzheimer's & MS treatments with foralumab. Key trials & market insights reveal exciting opportunities. See more.